Azithromycin-d3
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Azithromycin-d3
Description :
Azithromycin-d3 is the deuterium labeled Azithromycin. Azithromycin (CP-62993) is a macrolide antibiotic useful for the treatment of a number of bacterial infections[1][2].UNSPSC :
12352005Target :
Antibiotic; Autophagy; Bacterial; Isotope-Labeled CompoundsType :
Isotope-Labeled CompoundsRelated Pathways :
Anti-infection; Autophagy; OthersApplications :
COVID-19-immunoregulationField of Research :
Infection; CancerPurity :
99.7Solubility :
DMSO : ≥100 mg/mL (ultrasonic; warming) |Ethanol : ≥ 100mg/mLSmiles :
C[C@H]([C@@H](O[C@@]([H])([C@@H]1O)O[C@@H](C[C@@H]1N(C)C)C)[C@](C[C@@H](C)CN2C([2H])([2H])[2H])(C)O)[C@H](O[C@@]([H])(C[C@]3(OC)C)O[C@H]([C@@H]3O)C)[C@@H](C)C(O[C@@H]([C@@](O)([C@@H]([C@H]2C)O)C)CC)=OMolecular Formula :
C38H69D3N2O12Molecular Weight :
752.00References & Citations :
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Menzel M, et al. Azithromycin augments rhinovirus-induced IFNβ via cytosolic MDA5 in experimental models of asthma exacerbation. Oncotarget. 2017 Mar 18.|[3]Vandooren J, et al. Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study. PLoS One. 2017 Apr 3;12 (4) :e0174853.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Isotope-Labeled CompoundsClinical Information :
No Development ReportedIsoform :
MacrolideCAS Number :
[163921-65-1]

